Our Recommendations
New Publications
- Report of the fifth WHO stakeholders meeting on gambiense and rhodesiense human African trypanosomiasis elimination (2023)
- Vector control and the elimination of gambiense human African trypanosomiasis (2022)
- The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020 (2022)
- Current Treatments to Control African Trypanosomiasis and One Health Perspective (2022)
- Elimination of human African trypanosomiasis as public health problem (2022)
Filter
41
Featured
Language
Document type
Studies & Reports
23
Guidelines
5
Situation Updates
3
Resource Platforms
3
Strategic & Response Plan
3
Manuals
1
Infographics
1
Fact sheets
1
No document type
1
Countries / Regions
Africa
18
West and Central Africa
9
East and Southern Africa
8
Global
5
Middle East and North Africa
4
Uganda
4
Southern Africa
3
Congo, Democratic Republic of
2
Angola
2
South Sudan
2
Benin
1
Rwanda
1
Cameroon
1
Guinea
1
Tanzania
1
Côte d’Ivoire / Ivory Coast
1
South Africa
1
Chad
1
Authors & Publishers
Publication Years
Category
Human African Trypanosomiasis
3
Vector Control
1
Policies
1
Toolboxes
Clinical Aspects & Diagnostics
18
Studies & Reports
15
Policies & Strategies
3
Capacity Building & Resources
2
Information & Education Material (IEC)
2
Statistics & Facts
1
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
The previous report of the WHO Expert Committee on this disease
followed a meeting in 1995. Intensive, coordinated efforts against HAT during
the intervening 18 years have resulted in a decrease in incidence to a point at
which elimination is considered feasible. This report provides informati...
Background: East African trypanosomiasis is an uncommon, potentially lethal disease if not diagnosed and treated in a timely manner. South Africa, as a centre for emergency medical evacuations from much of sub-Saharan Africa, receives a high proportion of these patients, mostly tourists and expatria...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
In 2012, the World Health Organisation (WHO) set out a roadmap for the control, elimination, or eradication of 17 neglected tropical diseases by 2020. Many were skeptical about the achievability of such goals. Now, still two years away from that end point, good news is emerging for gambiense human A...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Sleeping sickness is a neglected tropical disease affecting rural communities in sub-Saharan Africa. The reduction in the number of reported cases in recent years indicates that disease transmission is under control. However, many aspects of patient management still need to be improved. Undiagnosed ...
